• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素相关蛋白在肿瘤性高钙血症患者中的诊断意义

[Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].

作者信息

Blind E, Raue F, Meinel T, Pecherstorfer M, Räth U, Schmidt-Gayk H, Kohl B, Ziegler R

机构信息

Abteilung Innere Medizin I, Medizinische Universitätsklinik Heidelberg.

出版信息

Dtsch Med Wochenschr. 1993 Mar 12;118(10):330-5. doi: 10.1055/s-2008-1059333.

DOI:10.1055/s-2008-1059333
PMID:8453901
Abstract

The clinical utility of measuring parathormone-related protein (PTHrP) was investigated in 94 patients (48 men, 46 women, mean age 56 [18-82] years) with tumour-associated hypercalcaemia, using a radioimmunoassay directed against the middle portion (53-84) of PTHrP (reference range < 5-21 pmol/l). Increased levels of the middle portion of PTHrP were found in 44 of the 73 patients (60%) with hypercalcaemia associated with solid tumours (median 49 [22-333] pmol/l). There was a positive correlation between the serum calcium concentration and the PTHrP (P = 0.018). The frequency of a raised PTHrP, indicating hormone-induced hypercalcaemia, was similar in patients with and without bone metastases (48% vs 66%). Elevated PTHrP was particularly frequent in patients with squamous cell carcinomas (17 out of 21; 81%), while PTHrP levels were normal in 18 out of the 21 patients with hypercalcaemia associated with haematological malignancies. PTHrP levels were normal in 37 out of 38 normocalcaemic tumour patients and in 30 out of 32 patients with primary hyperparathyroidism. Hypercalcaemia associated with benign disease was found in only one case, a female with marked benign breast hypertrophy.--The measurement of PTHrP allows the demonstration of a pathogenetic factor in tumour-associated hypercalcaemia, and differentiation from other causes of hypercalcaemia, in particular primary hyperparathyroidism.

摘要

采用针对甲状旁腺激素相关蛋白(PTHrP)中间部分(53 - 84)的放射免疫分析法,对94例肿瘤相关性高钙血症患者(48例男性,46例女性,平均年龄56岁[18 - 82岁])进行了PTHrP检测临床效用的研究(参考范围<5 - 21 pmol/L)。在73例实体瘤相关性高钙血症患者中,44例(60%)患者的PTHrP中间部分水平升高(中位数49 [22 - 333] pmol/L)。血清钙浓度与PTHrP之间呈正相关(P = 0.018)。有无骨转移患者中提示激素诱导性高钙血症的PTHrP升高频率相似(48%对66%)。PTHrP升高在鳞状细胞癌患者中尤为常见(21例中有17例;81%),而在21例血液系统恶性肿瘤相关性高钙血症患者中,有18例PTHrP水平正常。38例血钙正常的肿瘤患者中有37例PTHrP水平正常,32例原发性甲状旁腺功能亢进患者中有30例PTHrP水平正常。仅1例良性疾病相关性高钙血症患者被发现,为一名患有明显良性乳腺肥大的女性。——PTHrP检测有助于明确肿瘤相关性高钙血症的致病因素,并与其他高钙血症原因相鉴别,尤其是原发性甲状旁腺功能亢进。

相似文献

1
[Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].甲状旁腺激素相关蛋白在肿瘤性高钙血症患者中的诊断意义
Dtsch Med Wochenschr. 1993 Mar 12;118(10):330-5. doi: 10.1055/s-2008-1059333.
2
Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.癌症所致体液性高钙血症患者循环中甲状旁腺激素相关蛋白的免疫化学特征
N Engl J Med. 1990 Apr 19;322(16):1106-12. doi: 10.1056/NEJM199004193221603.
3
Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.与血钙正常和高钙血症相关的实体瘤中甲状旁腺激素相关蛋白(PTHrP)基因的表达
J Pathol. 1993 Nov;171(3):215-21. doi: 10.1002/path.1711710310.
4
Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.恶性肿瘤相关性高钙血症:一项关于临床特征以及循环钙水平、甲状旁腺激素和甲状旁腺激素相关肽之间关系的研究。
J Med Assoc Thai. 2007 Apr;90(4):663-71.
5
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.恶性肿瘤高钙血症时血循环中中段甲状旁腺激素相关蛋白的水平
Clin Endocrinol (Oxf). 1992 Sep;37(3):290-7. doi: 10.1111/j.1365-2265.1992.tb02324.x.
6
Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.甲状旁腺激素相关肽在高钙血症评估中的作用。
Rev Rhum Engl Ed. 1995 Mar;62(3):189-96.
7
Parathyroid hormone-related peptide, measured by a midmolecule radioimmunoassay, in various hypercalcaemic and normocalcaemic conditions.
Acta Endocrinol (Copenh). 1992 Oct;127(4):294-300. doi: 10.1530/acta.0.1270294.
8
[Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].[两种甲状旁腺激素相关肽(PTHrP)检测试剂盒在恶性高钙血症附加研究中的性能]
Pathol Biol (Paris). 1995 Nov;43(9):799-805.
9
Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.甲状旁腺激素相关蛋白、骨转移和恶性肿瘤高钙血症
Ann R Coll Surg Engl. 1996 Jul;78(4):354-8.
10
Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.甲状旁腺激素相关蛋白的尿排泄作为成人T细胞白血病患者高钙血症的预测指标
Jpn J Clin Oncol. 1992 Oct;22(5):325-30.

引用本文的文献

1
Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years.20年间167551例患者恶性肿瘤高钙血症的诊断检查及病因评估
J Endocr Soc. 2021 Oct 6;5(11):bvab157. doi: 10.1210/jendso/bvab157. eCollection 2021 Nov 1.